Treatment: how does inflammatory phenotype influence response to treatment in airway disease?

C. Brightling (Leicester, United Kingdom)

Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Session: Inflammatory phenotypes in airway disease
Session type: Symposium
Number: 3982
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Brightling (Leicester, United Kingdom). Treatment: how does inflammatory phenotype influence response to treatment in airway disease?. Annual Congress 2007 - Inflammatory phenotypes in airway disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006

Reduced eosinophil apoptosis in induced sputum correlates with asthma severity
Source: Eur Respir J 2003; 22: 484-490
Year: 2003

Airway inflammation: assessment of neutrophil apoptosis in induced sputum
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005

Inflammatory cell activation in eosinophilic and non-eosinophilic asthma
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006

The verdict
Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease
Year: 2006

Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006

Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response
Source: Eur Respir J 2003; 22: 118-126
Year: 2003

IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

Mechanisms of noneosinophilic asthma
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007

An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity?
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001

Eosinophilic inflammation in sputum of poorly controlled asthmatics
Source: Eur Respir J 2002; 20: 1370-1377
Year: 2002

Eotaxin-2 in sputum cell culture to evaluate asthma inflammation
Source: Eur Respir J 2007; 29: 489-495
Year: 2007

The influence of gluco-corticoids (GC) on the apoptosis of activated cells in the induced sputum of patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002

The development of an airway hyperresponsiveness (AHR) depends on mast cells following sensitization without adjuvant
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006

Differential gene expression and cytokine production from neutrophils in asthma phenotypes
Source: Eur Respir J 2010; 35: 522-531
Year: 2010

Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005

Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Source: Respipedia Article
Year: 2018

Rhinitis, nasal polyposis and asthma: pathological aspects
Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115
Year: 2001

Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 640-646
Year: 2005